Cortera Neurotechnologies Inc. has developed a neurostimulation device that can simultaneously monitor and stimulate the brain, which they note as a first in the field. There are existing closed loop neurostimulators but enabling brain monitoring throughout stimulation had remained a technical hurdle.

HAMBURG, Germany – Edwards Lifesciences Corp. received U.S. FDA approval to market its Sapien 3 Ultra system for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are at intermediate or greater risk of open-heart surgery.